(Q66392967)
Statements
A Phase I/II Basket Trial of the EGF Vaccine CIMAvax in Combination With Anti-PD1 Therapy in Patients With Advanced NSCLC or Squamous Head and Neck Cancer (English)
0 references
22 December 2016
0 references
9 June 2020
0 references
181
0 references
18 year
0 references